readthroughSign in
CompanyCGEMNasdaqCambridge, MA

Cullinan Therapeutics Inc.

Cullinan Therapeutics develops T cell engagers for autoimmune diseases and cancer.

10-QNov 16Latest SEC filing
Nov 17Latest story